NuVasive’s XLIF procedure is backed by 10-plus years of clinical evidence.
Here are four observations:
1. The market is set to hit about $2.6 billion by 2024.
2. In 2016, the market was worth about $1.6 billion.
3. Key drivers include the increasing demand of minimally invasive procedures and growing number of spinal disorder cases.
4. The procedure’s costliness, unfavorable reimbursements and a boost in alternative treatments will hinder market growth.
More articles on MIS:
Life Spine launches SI joint fixation screw system
Columbia University Medical Center performs 1st surgery using Titan Medical’s Sport Surgical System: 5 insights
Florida Hospital 1st in US to install minimally invasive surgical robot: 5 notes
